27626044|t|Amphetamine- and methamphetamine-induced hyperthermia: Implications of the effects produced in brain vasculature and peripheral organs to forebrain neurotoxicity.
27626044|a|The adverse effects of amphetamine- (AMPH) and methamphetamine- (METH) induced hyperthermia on vasculature, peripheral organs and peripheral immune system are discussed. Hyperthermia alone does not produce amphetamine-like neurotoxicity but AMPH and METH exposures that do not produce hyperthermia (>=40 C) are minimally neurotoxic. Hyperthermia likely enhances AMPH and METH neurotoxicity directly through disruption of protein function, ion channels and enhanced ROS production. Forebrain neurotoxicity can also be indirectly influenced through the effects of AMPH- and METH- induced hyperthermia on vasculature. The hyperthermia and the hypertension produced by high doses amphetamines are a primary cause of transient breakdowns in the blood-brain barrier (BBB) resulting in concomitant regional neurodegeneration and neuroinflammation in laboratory animals. This BBB breakdown can occur in the amygdala, thalamus, striatum, sensory and motor cortex and hippocampus. Under these conditions, repetitive seizures greatly enhance neurodegeneration in hippocampus, thalamus and amygdala. Even when the BBB is less disrupted, AMPH- or METH- induced hyperthermia effects on brain vasculature may play a role in neurotoxicity. In this case, striatal and cortical vascular function are adversely affected, and even greater ROS, immune and damage responses are seen in the meninges and cortical surface vasculature. Finally, muscle and liver damage and elevated cytokines in blood can result when amphetamines produce hyperthermia. Proteins, from damaged muscle may activate the peripheral immune system and exacerbate liver damage. Liver damage can further increase cytokine levels, immune system activation and increase ammonia levels. These effects could potentially enhance vascular damage and neurotoxicity. 
27626044	0	11	Amphetamine	Chemical	MESH:D000661
27626044	17	32	methamphetamine	Chemical	MESH:D008694
27626044	41	53	hyperthermia	Disease	MESH:D005334
27626044	138	161	forebrain neurotoxicity	Disease	MESH:C566067
27626044	186	197	amphetamine	Chemical	MESH:D000661
27626044	200	204	AMPH	Chemical	MESH:D000661
27626044	210	225	methamphetamine	Chemical	MESH:D008694
27626044	228	232	METH	Chemical	MESH:D008694
27626044	242	254	hyperthermia	Disease	MESH:D005334
27626044	333	345	Hyperthermia	Disease	MESH:D005334
27626044	369	380	amphetamine	Chemical	MESH:D000661
27626044	386	399	neurotoxicity	Disease	MESH:D020258
27626044	404	408	AMPH	Chemical	MESH:D000661
27626044	413	417	METH	Chemical	MESH:D008694
27626044	448	460	hyperthermia	Disease	MESH:D005334
27626044	484	494	neurotoxic	Disease	MESH:D020258
27626044	496	508	Hyperthermia	Disease	MESH:D005334
27626044	525	529	AMPH	Chemical	MESH:D000661
27626044	534	538	METH	Chemical	MESH:D008694
27626044	539	552	neurotoxicity	Disease	MESH:D020258
27626044	628	631	ROS	Chemical	-
27626044	644	667	Forebrain neurotoxicity	Disease	MESH:C566067
27626044	725	729	AMPH	Chemical	MESH:D000661
27626044	735	739	METH	Chemical	MESH:D008694
27626044	749	761	hyperthermia	Disease	MESH:D005334
27626044	782	794	hyperthermia	Disease	MESH:D005334
27626044	803	815	hypertension	Disease	MESH:D006973
27626044	839	851	amphetamines	Chemical	MESH:D000662
27626044	963	980	neurodegeneration	Disease	MESH:D019636
27626044	985	1002	neuroinflammation	Disease	MESH:D000090862
27626044	1169	1177	seizures	Disease	MESH:D012640
27626044	1194	1211	neurodegeneration	Disease	MESH:D019636
27626044	1288	1292	AMPH	Chemical	MESH:D000661
27626044	1297	1301	METH	Chemical	MESH:D008694
27626044	1311	1323	hyperthermia	Disease	MESH:D005334
27626044	1372	1385	neurotoxicity	Disease	MESH:D020258
27626044	1482	1485	ROS	Chemical	-
27626044	1583	1606	muscle and liver damage	Disease	MESH:D056486
27626044	1655	1667	amphetamines	Chemical	MESH:D000662
27626044	1676	1688	hyperthermia	Disease	MESH:D005334
27626044	1777	1789	liver damage	Disease	MESH:D056486
27626044	1791	1803	Liver damage	Disease	MESH:D056486
27626044	1880	1887	ammonia	Chemical	MESH:D000641
27626044	1936	1951	vascular damage	Disease	MESH:D057772
27626044	1956	1969	neurotoxicity	Disease	MESH:D020258
27626044	Positive_Correlation	MESH:D000661	MESH:D020258
27626044	Positive_Correlation	MESH:D000662	MESH:D006973
27626044	Positive_Correlation	MESH:D008694	MESH:D005334
27626044	Positive_Correlation	MESH:D000641	MESH:D056486
27626044	Positive_Correlation	MESH:D008694	MESH:C566067
27626044	Positive_Correlation	MESH:D000662	MESH:D019636
27626044	Positive_Correlation	MESH:D000662	MESH:D005334
27626044	Positive_Correlation	MESH:D000661	MESH:D005334
27626044	Positive_Correlation	MESH:D000661	MESH:C566067
27626044	Positive_Correlation	MESH:D008694	MESH:D020258
27626044	Positive_Correlation	MESH:D000662	MESH:D000090862
27626044	Positive_Correlation	MESH:D000662	MESH:D056486

